» Articles » PMID: 32732978

Alpha-lipoic Acid Protects Against Pressure Overload-induced Heart Failure Via ALDH2-dependent Nrf1-FUNDC1 Signaling

Overview
Journal Cell Death Dis
Date 2020 Aug 1
PMID 32732978
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Alpha-lipoic acid (α-LA), a well-known antioxidant, was proved to active ALDH2 in nitrate tolerance and diabetic animal model. However, the therapeutic advantage of α-LA for heart failure and related signaling pathway have not been explored. This study was designed to examine the role of α-LA-ALDH2 in heart failure injury and mitochondrial damage. ALDH2 knockout (ALDH2) mice and primary neonatal rat cardiomyocytes (NRCMs) were subjected to assessment of myocardial function and mitochondrial autophagy. Our data demonstrated α-LA significantly reduced the degree of TAC-induced LV hypertrophy and dysfunction in wild-type mice, not in ALDH2 mice. In molecular level, α-LA significantly restored ALDH2 activity and expression as well as increased the expression of a novel mitophagy receptor protein FUNDC1 in wild-type TAC mice. Besides, we confirmed that ALDH2 which was activated by α-LA governed the activation of Nrf1-FUNDC1 cascade. Our data suggest that α-LA played a positive role in protecting the heart against adverse effects of chronic pressure overload.

Citing Articles

Mechanisms and preventive measures of ALDH2 in ischemia‑reperfusion injury: Ferroptosis as a novel target (Review).

Han L, Zhai W Mol Med Rep. 2025; 31(4).

PMID: 40017132 PMC: 11876945. DOI: 10.3892/mmr.2025.13470.


Research Hotspots and Frontier Trends of Autophagy in Diabetic Cardiomyopathy From 2014 to 2024: A Bibliometric Analysis.

Yan M, Zhang S, Liang P, Huang H, Li G, A R J Multidiscip Healthc. 2025; 18:837-860.

PMID: 39963325 PMC: 11831922. DOI: 10.2147/JMDH.S507217.


Antrodia cinnamomea triterpenoids attenuate cardiac hypertrophy via the SNW1/RXR/ALDH2 axis.

Ma Y, Wang Y, Anwaier G, Tuerdi N, Wu Y, Huang Y Redox Biol. 2024; 78:103437.

PMID: 39591904 PMC: 11626818. DOI: 10.1016/j.redox.2024.103437.


ALDH2 mediates the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on improving cardiac remodeling.

Liu H, Jiang B, Hua R, Liu X, Qiao B, Zhang X Cardiovasc Diabetol. 2024; 23(1):380.

PMID: 39462342 PMC: 11520054. DOI: 10.1186/s12933-024-02477-8.


Advances in Factors Affecting ALDH2 Activity and its Mechanisms.

Liu Y, Liu X, Pan C Cardiovasc Toxicol. 2024; 24(12):1428-1438.

PMID: 39365551 DOI: 10.1007/s12012-024-09923-9.


References
1.
Bui A, Horwich T, Fonarow G . Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2010; 8(1):30-41. PMC: 3033496. DOI: 10.1038/nrcardio.2010.165. View

2.
Bayeva M, Gheorghiade M, Ardehali H . Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol. 2012; 61(6):599-610. PMC: 3594689. DOI: 10.1016/j.jacc.2012.08.1021. View

3.
Marunouchi T, Tanonaka K . Cell Death in the Cardiac Myocyte. Biol Pharm Bull. 2015; 38(8):1094-7. DOI: 10.1248/bpb.b15-00288. View

4.
Jackson B, Brocker C, Thompson D, Black W, Vasiliou K, Nebert D . Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum Genomics. 2011; 5(4):283-303. PMC: 3392178. DOI: 10.1186/1479-7364-5-4-283. View

5.
Shen C, Wang C, Fan F, Yang Z, Cao Q, Liu X . Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway. Biochim Biophys Acta. 2014; 1852(2):310-8. DOI: 10.1016/j.bbadis.2014.07.014. View